The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner

被引:15
|
作者
Shanzer, M. [1 ]
Ricardo-Lax, I. [1 ]
Keshet, R. [1 ]
Reuven, N. [1 ]
Shaul, Y. [1 ]
机构
[1] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel
基金
以色列科学基金会;
关键词
CELL CONTACT INHIBITION; MAMMARY-TUMORS; SIZE-CONTROL; TAZ; YAP; PHOSPHORYLATION; INDUCTION; IDENTIFICATION; TRANSFORMATION; PROLIFERATION;
D O I
10.1038/onc.2014.347
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The polyomavirus middle T antigen (PyMT) is an oncogene that activates the non-receptor tyrosine kinase, c-Src, and physically interacts with Taz (WWTR1). Taz is a pro-oncogenic transcription coactivator of the Tead transcription factors. The Hippo tumor suppressor pathway activates the kinase Lats, which phosphorylates Taz, leading to its nuclear exclusion and blunting Tead coactivation. We found that Taz was required for transformation by PyMT, but counter-intuitively, Taz was exclusively cytoplasmic in the presence of PyMT. We demonstrate that in the presence of PyMT, wild-type Taz was phosphorylated by Lats, in a Src-dependent manner. Consistently, a Lats refractory Taz mutant did not undergo cytoplasmic retention by PyMT. We show that Yap, the Taz paralog, and Shp2 phosphatase were nuclear excluded as well. Our findings describe a noncanonical activation of Lats, and an unprecedented Tead-independent role for Taz and Yap in viral-mediated oncogenesis.
引用
收藏
页码:4190 / 4198
页数:9
相关论文
共 18 条
  • [1] The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner
    M Shanzer
    I Ricardo-Lax
    R Keshet
    N Reuven
    Y Shaul
    Oncogene, 2015, 34 : 4190 - 4198
  • [2] Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1
    Si, Yuan
    Ji, Xinyan
    Cao, Xiaolei
    Dai, Xiaoming
    Xu, Lingyi
    Zhao, Hongxia
    Guo, Xiaocan
    Yan, Huan
    Zhang, Haitao
    Zhu, Chu
    Zhou, Qi
    Tang, Mei
    Xia, Zongping
    Li, Li
    Cong, Yu-Sheng
    Ye, Sheng
    Liang, Tingbo
    Feng, Xin-Hua
    Zhao, Bin
    CANCER RESEARCH, 2017, 77 (18) : 4868 - 4880
  • [3] MECHANISM OF ACTIVATION OF COMPLEXED PP60C-SRC BY THE MIDDLE T-ANTIGEN OF POLYOMAVIRUS
    CHENG, SH
    HARVEY, R
    PIWNICAWORMS, H
    ESPINO, PC
    ROBERTS, TM
    SMITH, AE
    CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY, 1989, 144 : 109 - 120
  • [4] Small T-antigen of the TS-associated polyomavirus activates factors implicated in the MAPK pathway
    Wu, J. H.
    Simonette, R. A.
    Nguyen, H. P.
    Rady, P. L.
    Tyring, S. K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (06) : 1061 - 1062
  • [5] ENDOTHELIAL-CELL TRANSFORMATION BY POLYOMAVIRUS MIDDLE T-ANTIGEN IN MICE LACKING SRC-RELATED KINASES
    KIEFER, F
    ANHAUSER, I
    SORIANO, P
    AGUZZI, A
    COURTNEIDGE, SA
    WAGNER, EF
    CURRENT BIOLOGY, 1994, 4 (02) : 100 - 109
  • [6] SIMULTANEOUS OVEREXPRESSION OF AVIAN PP60C-SRC AND POLYOMAVIRUS MIDDLE T-ANTIGEN IN MAMMALIAN-CELLS
    COOK, DN
    PAVLOFF, N
    HASSELL, JA
    JOURNAL OF VIROLOGY, 1990, 64 (05) : 2392 - 2395
  • [7] INDUCTION OF TUMOR-FORMATION AND CELL-TRANSFORMATION BY POLYOMA MIDDLE T-ANTIGEN IN THE ABSENCE OF SRC
    THOMAS, JE
    AGUZZI, A
    SORIANO, P
    WAGNER, EF
    BRUGGE, JS
    ONCOGENE, 1993, 8 (09) : 2521 - 2529
  • [8] THE TUMOR PROMOTOR TPA ACTS ON CELLS TRANSFORMED BY POLYOMAVIRUS MIDDLE T-ANTIGEN TO PRODUCE A HIGHLY TRANSFORMED PHENOTYPE
    STOLL, E
    CUZIN, F
    EXPERIENTIA, 1985, 41 (06): : 812 - 813
  • [9] pp60(c-src) binding to polyomavirus middle T-antigen (MT) requires residues 185 to 210 of the MT sequence
    Brewster, CEP
    Glover, HR
    Dilworth, SM
    JOURNAL OF VIROLOGY, 1997, 71 (07) : 5512 - 5520
  • [10] POLYOMAVIRUS MIDDLE T-ANTIGEN INDUCES RIBOSOMAL-PROTEIN S6 PHOSPHORYLATION THROUGH PP60C-SRC-DEPENDENT AND PP60C-SRC-INDEPENDENT PATHWAYS
    TALMAGE, DA
    BLENIS, J
    BENJAMIN, TL
    MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (06) : 2309 - 2315